SOTAC2026-09-08SOTAC2026-09-082026-09-08RelatedPartyTransactionDomain1SOTAC2026-09-082026-09-08RelatedPartyTransactionDomain2SOTAC2026-09-082026-09-08ResolutionOrAgendaDomain1SOTAC2026-09-08ResolutionOrAgendaDomain1SOTAC2026-09-082026-09-08ResolutionOrAgendaDomain2SOTAC2026-09-08ResolutionOrAgendaDomain2SOTAC2026-09-082026-09-08ResolutionOrAgendaDomain3SOTAC2026-09-08ResolutionOrAgendaDomain3SOTAC2026-09-082026-09-08ResolutionOrAgendaDomain4SOTAC2026-09-08ResolutionOrAgendaDomain4SOTAC2026-09-082026-09-08ResolutionOrAgendaDomain5SOTAC2026-09-08ResolutionOrAgendaDomain5SOTAC2026-09-082026-09-08ResolutionOrAgendaDomain6SOTAC2026-09-08ResolutionOrAgendaDomain6iso4217:INRxbrli:pureSOTACSotac Pharmaceuticals LimitedNew2026-09-0819:30:00We have added tenure of Director retired by rotation due to XBRL error only, there is No Specific Tenure of him its on going tenure of Executive director. 2026-09-08Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)1Wednesday2026-09-3011:00:00Ahmedabad6Sotac Pharmaceuticals LimitedSotac Healthcare Private LimitedSubsidiary companyAny other transactionPurchase of Raw Materials, Packing material, Finished goods, Sale of Raw Material and Sale of Products and for any other purchase and sale transactions from time to time and the ability to supply, provision/availing of services, Loans and Advances, borrowings including interest and Inter Corporate Deposit, other transactions permissible under applicable laws including Reimbursement of Expenses8500000002026-04-012027-03-31Sotac Pharmaceuticals LimitedSotac Lifesciences Private LimitedSubsidiary companyAny other transactionPurchase of Raw Materials, Packing material, Finished goods, Sale of Raw Material and Sale of Products and for any other purchase and sale transactions from time to time and the ability to supply, provision/availing of services, Loans and Advances, borrowings including interest and Inter Corporate Deposit, other transactions permissible under applicable laws including Reimbursement of Expenses8500000002026-04-012027-03-31Ordinary ResolutionAdoption of Financial StatementsAdoption of Audited Standalone and Consolidated Financial Statement of the Company for the Financial Year ended on March 31, 2026 and the report of the Board of Directors and Auditors thereonOrdinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo appoint a director in place of Mr. Sharadkumar Dashrathbhai Patel (DIN: 07252252), who retires by rotation and being eligible, offers himself for re-appointmentOthersManaging DirectorMr. Sharadkumar Dashrathbhai Patel2026-09-072027-09-06Ordinary ResolutionOthersOthersTo declare final dividend of Rs. 0.20/- (Ten paisa only) per Equity share of face value Rs.10/- each (i.e. 2% of face value) for the financial year ended on March 31, 2026To declare final dividend of Rs. 0.20/- (Ten paisa only) per Equity share of face value Rs.10/- each (i.e. 2% of face value) for the financial year ended on March 31, 2026Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRemunerationTo ratify the remuneration payable to M/s. Suthar Haresh & Associates, Cost Accountants (FRN.: 002124) Cost Auditor of the Company for the Financial Year ended on March 31, 2027OthersCost AuditorsM/s. Suthar Haresh & Associates, Cost Accountants2026-04-012027-03-3150000Ordinary ResolutionRelated Party TransactionTo Approve the Material related party transaction(s) proposed to be entered into by the Company during the FY 2026-27 with Sotac Healthcare Private Limited (“Subsidiary company”)Ordinary ResolutionRelated Party TransactionTo Approve the Material related party transaction(s) proposed to be entered into by the Company during the FY 2026-27 with Sotac Lifesciences Private Limited (“Subsidiary company”)